perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate is a biomedical product for cancer drug development. It exhibits potent inhibitory effects against specific tumor cells, enhancing their susceptibility to chemotherapy. This product's unique chemical properties aid in delivering targeted therapies to tumor sites, minimizing off-target effects.
Structure of
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00487 | perfluorophenyl 3-(pyridin-2-yldisulfanyl)propanoate | 160580-70-1 | |
BADC-00426 | Perfluorophenyl 2-(cyclooct-2-ynyloxy)acetate | 886209-60-5 | |
BADC-00468 | perfluorophenyl 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate | ||
BADC-00481 | perfluorophenyl 4-(pyridin-2-yldisulfanyl)butanoate | ||
BADC-00383 | perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate | ||
BADC-00385 | perfluorophenyl 3-(2-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)ethoxy)propanoate | ||
BADC-00387 | perfluorophenyl 3-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)propanoate | ||
BADC-00400 | perfluorophenyl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate | ||
BADC-00402 | perfluorophenyl 3-(2-(4-formylbenzamido)ethoxy)propanoate | ||
BADC-00420 | perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.